Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn about in brain "fog" complaints associated with long-COVID in people aged 22-50-years. The main questions it aims to answer are: * the natural course of brain "fog" complaints * the effect, if any of supplemental dietary oil on brain "fog" complaints Participants will be asked to undergo some brain testing (X-rays and questions. Treatments they'll be given will be one of two supplemental oils to consume daily. Researchers will compare outcomes in the two different oil groups to see if it has any effect on brain "fog" complaints.
Randomized placebo-control clinical trial comparing two types of nutritional oil and evaluating the impact, if any, on subjective complaints of long-COVID cognitive changes.
Age
22 - 50 years
Sex
ALL
Healthy Volunteers
No
University of Alberta
Edmonton, Alberta, Canada
Start Date
October 1, 2023
Primary Completion Date
July 30, 2026
Completion Date
March 1, 2027
Last Updated
July 8, 2025
100
ESTIMATED participants
medium chain triglyceride oil
DIETARY_SUPPLEMENT
Safflower oil
DIETARY_SUPPLEMENT
Lead Sponsor
University of Alberta
NCT06721949
NCT06631287
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06086366